Key Drivers
- Strong gross margin
- Recurring losses
- Positive Q4 cash
AIAI Summary
Gevo has shifted from a speculative ATJ/tech bet to an asset‑driven, near‑term cash‑generating industrial operator (GND + 45Z credits), so investors should now judge it as a project‑scale business where capital structure, credit monetization timing, and execution on debottlenecking matter as much as technology upside. The key actionable trigger: require repeatable quarterly positive operating cash flow and committed project financing for ATJ (or else remain watch/hold).
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong gross margin
- •Recurring losses
- •Positive Q4 cash
Gevo posts improving quarterly cash generation and a strong 47% gross margin but remains unprofitable for FY2025 with heavy opex, negative annual free cash flow, and a stretched EV/EBITDA that heightens valuation risk.
Price Behavior
Key Price Behavior Insights:
- •Above last month SMA
- •Near-term overbought
- •Resistance-tested highs
GEVO is in a short-term uptrend (price $2.27 > last month SMA ~$2.09) with strong but stretched momentum (14-day RSI ~72) facing immediate resistance near $2.38–$2.43 and support around $1.82–$1.90, so a clean breakout above $2.43 would signal continuation while a lost momentum could trigger a pullback to the support band.
Rapid rise from ~$1.89 on 2026-03-05 to $2.43 on 2026-03-12 indicating short-term volatility
Sentiment & News
Key News Insights:
- •Integration-driven change
- •Carbon revenue focus
- •SAF ramp plans
Gevo is transitioning to commercial operations after acquiring Red Trail, showing narrower losses, revenue beats and a new carbon-focused business while analysts remain cautiously mixed.
The Red Trail acquisition and carbon initiatives improve near-term profitability outlook but execution risk and mixed analyst sentiment keep the stock in a cautious trading range
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings